Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
US Department of Justice

Generated: November 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,808,716

« Back to Dashboard

Summary for Patent: 4,808,716

Title: 9-(phosponylmethoxyalkyl) adenines, the method of preparation and utilization thereof
Abstract:The invention relates to 9-(phosphonylmethoxyalkyl)adenines of the general formula I ##STR1## wherein R.sup.1 is a hydrogen atom, and alkyl group containing one to three carbon atoms, or a hydroxymethyl group, R.sup.2 is a methylene, ethylene, propylene, ethylidene, methoxyethylene, benzyloxyethylene, tetrahydropyran-2-yloxyethylene, (1-ethoxyethoxy)ethylene or 1,2-O-isopropylidene-1,2-dihydroxypropylene group the method of their preparation and utilization. Compounds of the general formula I exhibit biological effects (e.g. antiviral) or can be converted into compounds with such effects.
Inventor(s): Holy; Antonin (Praha, CS), Rosenberg; Ivan (Praha, CS)
Assignee: Ceskoslovenska akademic ved (CS)
Application Number:06/856,299
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 4,808,716

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Czechoslovakia3017-85Apr 25, 1985

International Patent Family for Patent: 4,808,716

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Czechoslovakia263951► Subscribe
Canada1295614► Subscribe
European Patent Office0206459► Subscribe
Germany3686002► Subscribe
Denmark167886► Subscribe
Denmark173625► Subscribe
Egypt18079► Subscribe
Australia5632886► Subscribe
Australia580151► Subscribe
Austria78259► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
US Army
Cantor Fitzgerald
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus